Literature DB >> 8324650

Interleukin-2: its biology and clinical application in patients with cancer.

J T Rubin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8324650     DOI： 10.3109/07357909309018878

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  3 in total

1.  Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon.

Authors:  H M Karpoff; M D'Angelica; S Blair; M D Brownlee; H Federoff; Y Fong
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model.

Authors:  W R Jarnagin; K Delman; D Kooby; S Mastorides; J Zager; M F Brennan; L H Blumgart; H Federoff; Y Fong
Journal:  Ann Surg       Date:  2000-05       Impact factor: 12.969

3.  Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact.

Authors:  G Alì; L Boldrini; M Lucchi; A Picchi; M Dell'Omodarme; M C Prati; A Mussi; V Corsi; G Fontanini
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.